These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 30224106)

  • 1. Methodological Issues in Assessing the Economic Value of Next-Generation Sequencing Tests: Many Challenges and Not Enough Solutions.
    Phillips KA; Deverka PA; Marshall DA; Wordsworth S; Regier DA; Christensen KD; Buchanan J
    Value Health; 2018 Sep; 21(9):1033-1042. PubMed ID: 30224106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valuation of Health and Nonhealth Outcomes from Next-Generation Sequencing: Approaches, Challenges, and Solutions.
    Regier DA; Weymann D; Buchanan J; Marshall DA; Wordsworth S
    Value Health; 2018 Sep; 21(9):1043-1047. PubMed ID: 30224107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Real-World Evidence in US Payer Coverage Decision-Making for Next-Generation Sequencing-Based Tests: Challenges, Opportunities, and Potential Solutions.
    Deverka PA; Douglas MP; Phillips KA
    Value Health; 2020 May; 23(5):540-550. PubMed ID: 32389218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using "Big Data" in the Cost-Effectiveness Analysis of Next-Generation Sequencing Technologies: Challenges and Potential Solutions.
    Wordsworth S; Doble B; Payne K; Buchanan J; Marshall DA; McCabe C; Regier DA
    Value Health; 2018 Sep; 21(9):1048-1053. PubMed ID: 30224108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Next-generation sequencing in oncology: challenges in economic evaluations.
    Ehman M; Punian J; Weymann D; Regier DA
    Expert Rev Pharmacoecon Outcomes Res; 2024 Dec; 24(10):1115-1132. PubMed ID: 39096135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "What Goes Around Comes Around": Lessons Learned from Economic Evaluations of Personalized Medicine Applied to Digital Medicine.
    Phillips KA; Douglas MP; Trosman JR; Marshall DA
    Value Health; 2017 Jan; 20(1):47-53. PubMed ID: 28212968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic Review of Economic Evaluations of Systemic Treatments for Advanced and Metastatic Gastric Cancer.
    Sharma S; Carey N; McConnell D; Lowery M; O'Sullivan J; McCullagh L;
    Pharmacoeconomics; 2024 Oct; 42(10):1091-1110. PubMed ID: 39060831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consideration for Employer-Based and Geographic Attributes Included in Value Assessment Methods of Next-Generation Sequencing Tests.
    Hart MR; Spencer SJ
    J Manag Care Spec Pharm; 2019 Aug; 25(8):936-940. PubMed ID: 31347979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PRIORITIES FOR HEALTH ECONOMIC METHODOLOGICAL RESEARCH: RESULTS OF AN EXPERT CONSULTATION.
    Tordrup D; Chouaid C; Cuijpers P; Dab W; van Dongen JM; Espin J; Jönsson B; Léonard C; McDaid D; McKee M; Miguel JP; Patel A; Reginster JY; Ricciardi W; Rutten-van Molken M; Rupel VP; Sach T; Sassi F; Waugh N; Bertollini R
    Int J Technol Assess Health Care; 2017 Jan; 33(6):609-619. PubMed ID: 29081308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic evaluation of diagnostic technology. Methodological challenges and viable solutions.
    Sassi F; McKee M; Roberts JA
    Int J Technol Assess Health Care; 1997; 13(4):613-30. PubMed ID: 9489253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allocating healthcare resources to genomic testing in Canada: latest evidence and current challenges.
    Weymann D; Dragojlovic N; Pollard S; Regier DA
    J Community Genet; 2022 Oct; 13(5):467-476. PubMed ID: 31273679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic Studies in Motor Neurone Disease: A Systematic Methodological Review.
    Moore A; Young CA; Hughes DA
    Pharmacoeconomics; 2017 Apr; 35(4):397-413. PubMed ID: 27975196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Review of the Challenges of Using Biomedical Big Data for Economic Evaluations of Precision Medicine.
    Fahr P; Buchanan J; Wordsworth S
    Appl Health Econ Health Policy; 2019 Aug; 17(4):443-452. PubMed ID: 30941659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Criteria list for assessment of methodological quality of economic evaluations: Consensus on Health Economic Criteria.
    Evers S; Goossens M; de Vet H; van Tulder M; Ament A
    Int J Technol Assess Health Care; 2005; 21(2):240-5. PubMed ID: 15921065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of B-Type Natriuretic Peptide (BNP) and N-Terminal proBNP (NT-proBNP) as Diagnostic Tests in Adults With Suspected Heart Failure: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(2):1-125. PubMed ID: 34055110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.
    McAleenan A; Jones HE; Kernohan A; Robinson T; Schmidt L; Dawson S; Kelly C; Spencer Leal E; Faulkner CL; Palmer A; Wragg C; Jefferies S; Brandner S; Vale L; Higgins JP; Kurian KM
    Cochrane Database Syst Rev; 2022 Mar; 3(3):CD013387. PubMed ID: 35233774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scenario drafting for early technology assessment of next generation sequencing in clinical oncology.
    Joosten SEP; Retèl VP; Coupé VMH; van den Heuvel MM; van Harten WH
    BMC Cancer; 2016 Feb; 16():66. PubMed ID: 26851938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic Evaluations of Next-Generation Precision Oncology: A Critical Review.
    Weymann D; Pataky R; Regier DA
    JCO Precis Oncol; 2018 Nov; 2():1-23. PubMed ID: 35135140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Development of the Guide to Economic Analysis and Research (GEAR) Online Resource for Low- and Middle-Income Countries' Health Economics Practitioners: A Commentary.
    Adeagbo CU; Rattanavipapong W; Guinness L; Teerawattananon Y
    Value Health; 2018 May; 21(5):569-572. PubMed ID: 29753354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing the Use of Next-Generation Sequencing Assays in Patients With Urothelial Carcinoma: Recommendations by the 2023 San Raffaele Retreat Panel.
    Tateo V; Cigliola A; Mercinelli C; Agarwal N; Grivas P; Kamat AM; Gibb EA; Moschini M; Brausi M; Dyrskjøt L; Loriot Y; Gupta S; Colecchia M; Spiess PE; Ross JS; Necchi A
    Clin Genitourin Cancer; 2024 Aug; 22(4):102091. PubMed ID: 38735133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.